Viewing Study NCT00073632


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2025-12-25 @ 7:34 PM
Study NCT ID: NCT00073632
Status: COMPLETED
Last Update Posted: 2013-11-06
First Post: 2003-12-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Acceptance-Based Treatment for Generalized Anxiety Disorder
Sponsor: University of Massachusetts, Boston
Organization:

Study Overview

Official Title: Developing a New Therapy for GAD: Acceptance-Based CBT
Status: COMPLETED
Status Verified Date: 2008-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will develop and implement an awareness- and acceptance-based for treatment of individuals with generalized anxiety disorder.
Detailed Description: Participants in this study are recruited from intakes at the Center for Anxiety and Related Disorders at Boston University. Participants will be randomly assigned to receive either acceptance and mindfulness-based strategies plus cognitive behavioral therapy or no treatment for 16 weeks. The treatment will involve daily practice of mindfulness techniques to help draw attention to and accept various emotional states. Interviews, questionnaires, and depression and anxiety scales will be used to assess participants. Assessments will be conducted post-treatment and at 3- and 9-month follow-up visits.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
R21MH063208 NIH None https://reporter.nih.gov/quic… View
DSIR AT-AS None None View